Historical source coverage

2021

262 selected records with a cited source date in 2021, shown 200 per page, newest first. This archive is selective and does not imply continuous monitoring or complete historical coverage.

Explore 2021 by record type

4 types

December 2021

20 records on this page

Literature metadata · Dalbavancin

Dalbavancin.

PubMed lists PMID 34598419 in Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia as Journal Article, Review, with publication-date metadata of 2021-09-30 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Daptomycin

What do beta-lactams add to vancomycin or daptomycin in the treatment of patients with methicillin-resistant Staphylococcus aureus bacteraemia? A review.

PubMed lists PMID 33563707 in Postgraduate medical journal as Journal Article, Review, with publication-date metadata of 2021-02-09 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · KPV

PubMed record PMID 34846053

PeptideScanner retained PubMed bibliographic metadata for PMID 34846053 at 2026-07-30T19:56:20.406Z. PubMed recorded a metadata revision date of 2021-12-23 and an Entrez history date of 2021-11-30. PeptideScanner associated this retained record with the identity slug kpv. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Daptomycin

Vancomycin or Daptomycin Plus a β-Lactam Versus Vancomycin or Daptomycin Alone for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: A Systematic Review and Meta-Analysis.

PubMed lists PMID 33728980 in Microbial drug resistance (Larchmont, N.Y.) as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2021-03-15 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Bivalirudin

Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial.

PubMed lists PMID 34491323 in European heart journal. Acute cardiovascular care as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2021-12-18 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Difelikefalin

Difelikefalin Acetate.

PubMed lists PMID 34849553 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, with publication-date metadata of 2022-01-01 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Bivalirudin

A Review of Bivalirudin for Pediatric and Adult Mechanical Circulatory Support.

PubMed lists PMID 33174088 in American journal of cardiovascular drugs : drugs, devices, and other interventions as Journal Article, Review, with publication-date metadata of 2020-11-10 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Glatiramer acetate

ClinicalTrials.gov record NCT01067521

PeptideScanner retained ClinicalTrials.gov record NCT01067521 at 2026-11-16T17:42:50.457Z. Its registry update date was 2021-12-09, and PeptideScanner's reviewed identity mapping was glatiramer-acetate.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Glatiramer acetate

ClinicalTrials.gov record NCT02499900

PeptideScanner retained ClinicalTrials.gov record NCT02499900 at 2026-11-16T17:42:50.457Z. Its registry update date was 2021-12-09, and PeptideScanner's reviewed identity mapping was glatiramer-acetate.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Dulaglutide

Acute Kidney Injury Occurring in a Patient Initiated on Dulaglutide.

PubMed lists PMID 34861012 in The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians as Journal Article, with publication-date metadata of 2018-06-25 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Etelcalcetide

Etelcalcetide (AMG 416), a peptide agonist of the calcium-sensing receptor, preserved cortical bone structure and bone strength in subtotal nephrectomized rats with established secondary hyperparathy…

PubMed lists PMID 28867373 in Bone as Journal Article, with publication-date metadata of 2017-09-01 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Enfuvirtide

Population pharmacokinetics of enfuvirtide in HIV-1-infected pediatric patients over 48 weeks of treatment.

PubMed lists PMID 17389560 in Journal of clinical pharmacology as Clinical Trial, Journal Article, Multicenter Study, with publication-date metadata of 2007-04 (month precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

November 2021

25 records on this page

Clinical trials · Elamipretide

ClinicalTrials.gov record NCT02693119

PeptideScanner retained ClinicalTrials.gov record NCT02693119 at 2026-07-30T19:56:31.565Z. Its registry update date was 2021-11-30, and PeptideScanner's reviewed identity mapping was elamipretide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Dihexa

AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway.

PubMed lists PMID 34827486 in Brain sciences as Journal Article, with publication-date metadata of 2021-11-11 (day precision). PeptideScanner associated the retained record with the identity slug dihexa. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Cerebrolysin

Diabetes exacerbates brain pathology following a focal blast brain injury: New role of a multimodal drug cerebrolysin and nanomedicine.

PubMed lists PMID 33223037 in Progress in brain research as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Review, with publication-date metadata of 2020-11-09 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Enfuvirtide

ClinicalTrials.gov record NCT01836068

PeptideScanner retained ClinicalTrials.gov record NCT01836068 at 2026-11-16T01:41:15.051Z. Its registry update date was 2021-11-23, and PeptideScanner's reviewed identity mapping was enfuvirtide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Degarelix

A Phase II, Randomized, Multicenter Study Comparing 10 Months versus 4 Months of Degarelix Therapy in Prolonging the Off Treatment Interval in Men with Localized Prostate Cancer Receiving Intermitten…

PubMed lists PMID 29534997 in The Journal of urology as Clinical Trial, Phase II, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2018-03-11 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT03357380

PeptideScanner retained ClinicalTrials.gov record NCT03357380 at 2026-07-30T19:56:31.568Z. Its registry update date was 2021-11-22, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Mecasermin

ClinicalTrials.gov record NCT00516386

PeptideScanner retained ClinicalTrials.gov record NCT00516386 at 2026-11-16T17:35:13.282Z. Its registry update date was 2021-11-18, and PeptideScanner's reviewed identity mapping was mecasermin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Triptorelin

ClinicalTrials.gov record NCT04846218

PeptideScanner retained ClinicalTrials.gov record NCT04846218 at 2026-11-15T21:49:16.513Z. Its registry update date was 2021-11-18, and PeptideScanner's reviewed identity mapping was triptorelin.

Source: ClinicalTrials.gov ↗

→

Regulatory · Daptomycin + 1 more

Federal Register notice 2021-25111

The Federal Register published notice 2021-25111, attributed to FDA and its parent HHS department, on 2021-11-18. Its official title is “Discovery Therapeutics, LLC, et al.; Withdrawal of Approval of 18 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Daptomycin and Eptifibatide.

Source: Federal Register via GovInfo ↗

→

Literature metadata · Abaloparatide

The use of abaloparatide to treat nonunion following dorsal closing wedge osteotomy for Freiberg's disease: A case report.

PubMed lists PMID 34786439 in Bone reports as Case Reports, Journal Article, with publication-date metadata of 2021-10-30 (day precision). PeptideScanner associated the retained record with the identity slug abaloparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Pasireotide

ClinicalTrials.gov record NCT02215070

PeptideScanner retained ClinicalTrials.gov record NCT02215070 at 2026-11-15T22:05:38.400Z. Its registry update date was 2021-11-17, and PeptideScanner's reviewed identity mapping was pasireotide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Glatiramer acetate

ClinicalTrials.gov record NCT00176592

PeptideScanner retained ClinicalTrials.gov record NCT00176592 at 2026-11-16T17:42:50.457Z. Its registry update date was 2021-11-16, and PeptideScanner's reviewed identity mapping was glatiramer-acetate.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT03611582

PeptideScanner retained ClinicalTrials.gov record NCT03611582 at 2026-07-30T19:56:31.576Z. Its registry update date was 2021-11-11, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Regulatory · Calcitonin salmon

Drugs@FDA application ANDA209358

The official Drugs@FDA dataset lists original submission 1 for ANDA 209358 with status AP dated 2021-11-10, and names calcitonin salmon among the application record's active ingredients.

Source: Drugs@FDA via openFDA ↗

→

Regulatory · Glucagon + 1 more

Federal Register notice 2021-24431

The Federal Register published notice 2021-24431, attributed to FDA and its parent HHS department, on 2021-11-09. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon and Leuprolide.

Source: Federal Register via GovInfo ↗

→

Clinical trials · Enfuvirtide

ClinicalTrials.gov record NCT00537394

PeptideScanner retained ClinicalTrials.gov record NCT00537394 at 2026-11-16T01:41:15.051Z. Its registry update date was 2021-11-04, and PeptideScanner's reviewed identity mapping was enfuvirtide.

Source: ClinicalTrials.gov ↗

→

Regulatory · Afamelanotide

Federal Register notice 2021-24074

The Federal Register published notice 2021-24074, attributed to FDA and its parent HHS department, on 2021-11-04. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; SCENESSE,” and PeptideScanner's exact reviewed identity mapping connects the document to Afamelanotide.

Source: Federal Register via GovInfo ↗

→

Clinical trials · Enfuvirtide

ClinicalTrials.gov record NCT00001118

PeptideScanner retained ClinicalTrials.gov record NCT00001118 at 2026-11-16T01:41:15.051Z. Its registry update date was 2021-11-01, and PeptideScanner's reviewed identity mapping was enfuvirtide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Enfuvirtide

ClinicalTrials.gov record NCT00031044

PeptideScanner retained ClinicalTrials.gov record NCT00031044 at 2026-11-16T01:41:15.051Z. Its registry update date was 2021-11-01, and PeptideScanner's reviewed identity mapping was enfuvirtide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Enfuvirtide

ClinicalTrials.gov record NCT00051831

PeptideScanner retained ClinicalTrials.gov record NCT00051831 at 2026-11-16T01:41:15.051Z. Its registry update date was 2021-11-01, and PeptideScanner's reviewed identity mapping was enfuvirtide.

Source: ClinicalTrials.gov ↗

→

October 2021

46 records on this page

Literature metadata · Cerebrolysin

Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer's disease: 30 years of clinical use.

PubMed lists PMID 32808294 in Medicinal research reviews as Journal Article, Review, with publication-date metadata of 2020-08-17 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Afamelanotide

ClinicalTrials.gov record NCT04943159

PeptideScanner retained ClinicalTrials.gov record NCT04943159 at 2026-07-30T19:57:27.404Z. Its registry update date was 2021-10-26, and PeptideScanner's reviewed identity mapping was afamelanotide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · GHRP-6

The GHS-R blocker D-[Lys3] GHRP-6 serves as CCR5 chemokine receptor antagonist.

PubMed lists PMID 22211090 in International journal of medical sciences as Journal Article, Research Support, N.I.H., Intramural, with publication-date metadata of 2011-11-18 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-6. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · GHRP-6

Identification of ghrelin receptor blocker, D-[Lys3] GHRP-6 as a CXCR4 receptor antagonist.

PubMed lists PMID 22211109 in International journal of biological sciences as Journal Article, Research Support, N.I.H., Intramural, with publication-date metadata of 2011-11-26 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-6. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Peginesatide

Peginesatide for maintenance treatment of anemia in hemodialysis and nondialysis patients previously treated with darbepoetin alfa.

PubMed lists PMID 23243269 in Clinical journal of the American Society of Nephrology : CJASN as Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2012-12-14 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Glatiramer acetate

Neuroprotection with glatiramer acetate: evidence from the PreCISe trial.

PubMed lists PMID 23589190 in Journal of neurology as Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-04-16 (day precision). PeptideScanner associated the retained record with the identity slug glatiramer-acetate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Peginesatide

Managing dialysis patients who develop anemia caused by chronic kidney disease: focus on peginesatide.

PubMed lists PMID 24023516 in International journal of nanomedicine as Journal Article, Review, with publication-date metadata of 2013-08-26 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Peginesatide

Peginesatide to Manage Anemia in Chronic Kidney Disease Patients on Peritoneal Dialysis.

PubMed lists PMID 24584613 in Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis as Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2014-03-01 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Secretin

The physiological roles of secretin and its receptor.

PubMed lists PMID 25332973 in Annals of translational medicine as Journal Article, Review, with publication-date metadata of 2013-10 (month precision). PeptideScanner associated the retained record with the identity slug secretin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Thymosin alpha-1

ClinicalTrials.gov record NCT05086614

PeptideScanner retained ClinicalTrials.gov record NCT05086614 at 2026-11-15T22:10:40.222Z. Its registry update date was 2021-10-21, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Eptifibatide

The kinetics of integrilin limited by obesity: a multicenter randomized pharmacokinetic and pharmacodynamic clinical trial.

PubMed lists PMID 22137072 in American heart journal as Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2011-11-08 (day precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Degarelix

Degarelix as a new antiangiogenic agent for metastatic colon cancer?

PubMed lists PMID 23431078 in World journal of gastroenterology as Case Reports, Journal Article, with publication-date metadata of 2013-02-07 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Degarelix

Tipping the balance in favour of degarelix for ADT.

PubMed lists PMID 24473414 in Nature reviews. Urology as Journal Article, with publication-date metadata of 2014-01-28 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Pramlintide

In silico design of optimal ratio for co-administration of pramlintide and insulin in type 1 diabetes.

PubMed lists PMID 23865841 in Diabetes technology & therapeutics as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-07-18 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Semax

Stability of Semax acetyl to proteolysis in various biological media.

PubMed lists PMID 23652441 in Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-05-08 (day precision). PeptideScanner associated the retained record with the identity slug semax. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Elamipretide

The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin.

PubMed lists PMID 23813215 in Journal of the American Society of Nephrology : JASN as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-07-11 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Semax

Study of proteolysis of Semax analogues with different N-terminal amino acids by carboxypeptidases.

PubMed lists PMID 23821053 in Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-07-03 (day precision). PeptideScanner associated the retained record with the identity slug semax. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Tesamorelin

Population pharmacokinetic analysis of tesamorelin in HIV-infected patients and healthy subjects.

PubMed lists PMID 25358450 in Clinical pharmacokinetics as Clinical Trial, Phase I, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-03 (month precision). PeptideScanner associated the retained record with the identity slug tesamorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · KPV

PubMed record PMID 34547895

PeptideScanner retained PubMed bibliographic metadata for PMID 34547895 at 2026-07-30T19:58:34.757Z. PubMed recorded a metadata revision date of 2021-10-21 and an Entrez history date of 2021-09-22. PeptideScanner associated this retained record with the identity slug kpv. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · KPV

PubMed record PMID 22837805

PeptideScanner retained PubMed bibliographic metadata for PMID 22837805 at 2026-07-30T19:58:22.828Z. PubMed recorded a metadata revision date of 2021-10-21 and an Entrez history date of 2012-07-28. PeptideScanner associated this retained record with the identity slug kpv. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Tesofensine

Contribution of the active metabolite M1 to the pharmacological activity of tesofensine in vivo: a pharmacokinetic-pharmacodynamic modelling approach.

PubMed lists PMID 17982477 in British journal of pharmacology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-11-05 (day precision). PeptideScanner associated the retained record with the identity slug tesofensine. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Calcitonin salmon

Salmon calcitonin: a review of current and future therapeutic indications.

PubMed lists PMID 18071651 in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA as Journal Article, Review, with publication-date metadata of 2007-12-11 (day precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Hexarelin

Hexarelin Signaling to PPARgamma in Metabolic Diseases.

PubMed lists PMID 18288286 in PPAR research as Journal Article, with publication-date metadata of 2008 (year precision). PeptideScanner associated the retained record with the identity slug hexarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Hexarelin

Hexarelin: a multi-receptor peptide.

PubMed lists PMID 18787392 in Journal of endocrinological investigation as Letter, with publication-date metadata of 2008-07 (month precision). PeptideScanner associated the retained record with the identity slug hexarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Tesofensine

A quantitative enterohepatic circulation model: development and evaluation with tesofensine and meloxicam.

PubMed lists PMID 19705923 in Clinical pharmacokinetics as Comparative Study, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009 (year precision). PeptideScanner associated the retained record with the identity slug tesofensine. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Humanin

Humanin and the receptors for humanin.

PubMed lists PMID 19997871 in Molecular neurobiology as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2009-12-09 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · PEG-MGF

Minireview: Mechano-growth factor: a putative product of IGF-I gene expression involved in tissue repair and regeneration.

PubMed lists PMID 20130113 in Endocrinology as Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., Review, with publication-date metadata of 2010-02-03 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Histrelin

Histrelin: in advanced prostate cancer.

PubMed lists PMID 20329807 in Drugs as Journal Article, Review, with publication-date metadata of 2010-03-26 (day precision). PeptideScanner associated the retained record with the identity slug histrelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Secretin

Consequences of splice variation on Secretin family G protein-coupled receptor function.

PubMed lists PMID 21718310 in British journal of pharmacology as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2012-05 (month precision). PeptideScanner associated the retained record with the identity slug secretin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Cetrorelix

In vivo biodistribution of an androgen receptor avid PET imaging agent 7-alpha-fluoro-17 alpha-methyl-5-alpha-dihydrotestosterone ([(18)F]FMDHT) in rats pretreated with cetrorelix, a GnRH antagonist.

PubMed lists PMID 17934727 in European journal of nuclear medicine and molecular imaging as Journal Article, Research Support, N.I.H., Extramural, with publication-date metadata of 2007-10-13 (day precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Melanotan II

The first preparative solution phase synthesis of melanotan II.

PubMed lists PMID 19043625 in Beilstein journal of organic chemistry as Journal Article, with publication-date metadata of 2008-10-30 (day precision). PeptideScanner associated the retained record with the identity slug melanotan-ii. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Cetrorelix

Fluorescence spectroscopic determination of the critical aggregation concentration of the GnRH antagonists Cetrorelix, Teverelix and Ozarelix.

PubMed lists PMID 20514551 in Journal of fluorescence as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010-06-01 (day precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Difelikefalin

ClinicalTrials.gov record NCT03998163

PeptideScanner retained ClinicalTrials.gov record NCT03998163 at 2026-11-15T21:56:33.343Z. Its registry update date was 2021-10-15, and PeptideScanner's reviewed identity mapping was difelikefalin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Abaloparatide

ClinicalTrials.gov record NCT03710889

PeptideScanner retained ClinicalTrials.gov record NCT03710889 at 2026-07-30T19:57:27.406Z. Its registry update date was 2021-10-15, and PeptideScanner's reviewed identity mapping was abaloparatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Afamelanotide

ClinicalTrials.gov record NCT00979745

PeptideScanner retained ClinicalTrials.gov record NCT00979745 at 2026-07-30T19:57:27.405Z. Its registry update date was 2021-10-12, and PeptideScanner's reviewed identity mapping was afamelanotide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Setmelanotide

Setmelanotide: First Approval.

PubMed lists PMID 33638809 in Drugs as Journal Article, Review, with publication-date metadata of 2021-02 (month precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Teduglutide

ClinicalTrials.gov record NCT02889393

PeptideScanner retained ClinicalTrials.gov record NCT02889393 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-10-06, and PeptideScanner's reviewed identity mapping was teduglutide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Icatibant

Continued icatibant use across recurrent attacks in adolescents with hereditary angioedema.

PubMed lists PMID 33851451 in Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology as Letter, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-05-11 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Afamelanotide

ClinicalTrials.gov record NCT04425746

PeptideScanner retained ClinicalTrials.gov record NCT04425746 at 2026-07-30T19:57:27.405Z. Its registry update date was 2021-10-01, and PeptideScanner's reviewed identity mapping was afamelanotide.

Source: ClinicalTrials.gov ↗

→

September 2021

15 records on this page

Literature metadata · Mecasermin

Efficient process development for high-level production, purification, formulation, and characterization of recombinant mecasermin in Escherichia coli.

PubMed lists PMID 32692415 in Biotechnology and applied biochemistry as Journal Article, with publication-date metadata of 2020-08-07 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Pasireotide

ClinicalTrials.gov record NCT03103009

PeptideScanner retained ClinicalTrials.gov record NCT03103009 at 2026-11-15T22:05:38.400Z. Its registry update date was 2021-09-29, and PeptideScanner's reviewed identity mapping was pasireotide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Daptomycin

The Global Prevalence of Daptomycin, Tigecycline, and Linezolid-Resistant Enterococcus faecalis and Enterococcus faecium Strains From Human Clinical Samples: A Systematic Review and Meta-Analysis.

PubMed lists PMID 34568377 in Frontiers in medicine as Systematic Review, Journal Article, with publication-date metadata of 2021-09-10 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Setmelanotide

Setmelanotide Acetate.

PubMed lists PMID 33787829 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, with publication-date metadata of 2021-03-31 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Setmelanotide

Setmelanotide (Imcivree) for rare genetic forms of obesity.

PubMed lists PMID 34544109 in The Medical letter on drugs and therapeutics as Journal Article, Review, with publication-date metadata of 2021-07-26 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Teduglutide

ClinicalTrials.gov record NCT03716115

PeptideScanner retained ClinicalTrials.gov record NCT03716115 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-09-27, and PeptideScanner's reviewed identity mapping was teduglutide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Lutetium Lu 177 dotatate

Phase I study of the 177Lu-DOTA0-Tyr3-Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lung.

PubMed lists PMID 32616557 in Journal for immunotherapy of cancer as Clinical Trial, Phase I, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-07 (month precision). PeptideScanner associated the retained record with the identity slug lutetium-lu-177-dotatate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Pasireotide

ClinicalTrials.gov record NCT00171730

PeptideScanner retained ClinicalTrials.gov record NCT00171730 at 2026-11-15T22:05:38.400Z. Its registry update date was 2021-09-05, and PeptideScanner's reviewed identity mapping was pasireotide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Icatibant

Management of hereditary angioedema in Japan: Focus on icatibant for the treatment of acute attacks.

PubMed lists PMID 32919903 in Allergology international : official journal of the Japanese Society of Allergology as Journal Article, Review, with publication-date metadata of 2020-09-09 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Regulatory · Exenatide

Federal Register notice 2021-18928

The Federal Register published notice 2021-18928, attributed to FDA and its parent HHS department, on 2021-09-02. Its official title is “Proposal To Refuse To Approve a New Drug Application for ITCA 650 (Exenatide in DUROS Device); Opportunity for a Hearing,” and PeptideScanner's exact reviewed identity mapping connects the document to Exenatide.

Source: Federal Register via GovInfo ↗

→

August 2021

15 records on this page

Literature metadata · Daptomycin

Daptomycin versus Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection with or without Endocarditis: A Systematic Review and Meta-Analysis.

PubMed lists PMID 34439067 in Antibiotics (Basel, Switzerland) as Journal Article, Review, with publication-date metadata of 2021-08-21 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Larazotide

[Larazotide as an option in case of failure of a gluten-free diet].

PubMed lists PMID 26983338 in Medizinische Monatsschrift fur Pharmazeuten as Journal Article, with publication-date metadata of 2016-02 (month precision). PeptideScanner associated the retained record with the identity slug larazotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Metreleptin

Metreleptin for the treatment of progressive encephalopathy with/without lipodystrophy (PELD) in a child with progressive myoclonic epilepsy: a case report.

PubMed lists PMID 33099310 in Italian journal of pediatrics as Case Reports, Journal Article, with publication-date metadata of 2020-10-24 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Regulatory · Difelikefalin

Drugs@FDA application NDA214916

The official Drugs@FDA dataset lists original submission 1 for NDA 214916 with status AP dated 2021-08-23, and names difelikefalin acetate among the application record's active ingredients.

Source: Drugs@FDA via openFDA ↗

→

Regulatory · Leuprolide + 1 more

Federal Register notice 2021-18072

The Federal Register published notice 2021-18072, attributed to FDA and its parent HHS department, on 2021-08-23. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide and Semaglutide.

Source: Federal Register via GovInfo ↗

→

Literature metadata · Dulaglutide

Dulaglutide for erectile dysfunction in type 2 diabetes.

PubMed lists PMID 34153270 in The lancet. Diabetes & endocrinology as Journal Article, Comment, with publication-date metadata of 2021-06-18 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Teduglutide

Colon polyps in patients with short bowel syndrome before and after teduglutide: Post hoc analysis of the STEPS study series.

PubMed lists PMID 31522784 in Clinical nutrition (Edinburgh, Scotland) as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-08-23 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Bivalirudin

Meta-analysis of bivalirudin versus heparin in transradial coronary interventions.

PubMed lists PMID 32091668 in Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2020-02-24 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Bivalirudin

The Use of Bivalirudin in Pediatric Cardiac Surgery and in the Interventional Cardiology Suite.

PubMed lists PMID 32127273 in Journal of cardiothoracic and vascular anesthesia as Journal Article, Review, with publication-date metadata of 2020-01-21 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

July 2021

8 records on this page

Regulatory · Eptifibatide

Federal Register notice 2021-16047

The Federal Register published notice 2021-16047, attributed to FDA and its parent HHS department, on 2021-07-28. Its official title is “Fresenius Kabi USA, LLC, et al.; Withdrawal of Approval of 15 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Eptifibatide.

Source: Federal Register via GovInfo ↗

→

Literature metadata · Setmelanotide

Setmelanotide: what does it mean for clinical care of patients with obesity?

PubMed lists PMID 33137294 in The lancet. Diabetes & endocrinology as Journal Article, Comment, with publication-date metadata of 2020-10-30 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Glepaglutide

ClinicalTrials.gov record NCT04318743

PeptideScanner retained ClinicalTrials.gov record NCT04318743 at 2026-11-16T01:46:56.290Z. Its registry update date was 2021-07-14, and PeptideScanner's reviewed identity mapping was glepaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Terlipressin

ClinicalTrials.gov record NCT03107091

PeptideScanner retained ClinicalTrials.gov record NCT03107091 at 2026-11-15T21:47:40.408Z. Its registry update date was 2021-07-13, and PeptideScanner's reviewed identity mapping was terlipressin.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Dalbavancin

Dalbavancin for the Treatment of Prosthetic Joint Infections: A Narrative Review.

PubMed lists PMID 34072670 in Antibiotics (Basel, Switzerland) as Journal Article, Review, with publication-date metadata of 2021-05-31 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Teduglutide

Teduglutide Therapy in 2 Patients With Short-Bowel Syndrome and Familial Adenomatous Polyposis.

PubMed lists PMID 32829492 in JPEN. Journal of parenteral and enteral nutrition as Case Reports, Journal Article, with publication-date metadata of 2020-09-07 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Secretin

The molecular mechanism of CFTR- and secretin-dependent renal bicarbonate excretion.

PubMed lists PMID 33963548 in The Journal of physiology as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2021-05-29 (day precision). PeptideScanner associated the retained record with the identity slug secretin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Dalbavancin

Dalbavancin treatment for prosthetic joint infections in real-life: a national cohort study and literature review.

PubMed lists PMID 33962065 in Journal of global antimicrobial resistance as Journal Article, Review, with publication-date metadata of 2021-05-04 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

June 2021

45 records on this page

Clinical trials · Dasiglucagon

ClinicalTrials.gov record NCT03667053

PeptideScanner retained ClinicalTrials.gov record NCT03667053 at 2026-11-16T01:42:39.027Z. Its registry update date was 2021-06-30, and PeptideScanner's reviewed identity mapping was dasiglucagon.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT02023411

PeptideScanner retained ClinicalTrials.gov record NCT02023411 at 2026-07-30T20:02:09.392Z. Its registry update date was 2021-06-30, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Teduglutide

Comprehensive nutritional assessment in short bowel syndrome with chronic renal failure on teduglutide therapy: A case report.

PubMed lists PMID 32088500 in Nutrition (Burbank, Los Angeles County, Calif.) as Case Reports, Journal Article, with publication-date metadata of 2020-01-07 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Dalbavancin

Dalbavancin for the management of osteomyelitis: a major step forward?

PubMed lists PMID 32457989 in The Journal of antimicrobial chemotherapy as Journal Article, Review, with publication-date metadata of 2020-10-01 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · GHRP-6

D-Lys-3-GHRP-6 impairs memory consolidation and downregulates the hippocampal serotonin HT1A, HT7 receptors and glutamate GluA1 subunit of AMPA receptors.

PubMed lists PMID 32454141 in Physiology & behavior as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-05-23 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-6. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Melanotan II

Melanotan II: a possible cause of renal infarction: review of the literature and case report.

PubMed lists PMID 31953620 in CEN case reports as Case Reports, Journal Article, Review, with publication-date metadata of 2020-01-18 (day precision). PeptideScanner associated the retained record with the identity slug melanotan-ii. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Daptomycin

Adjuvant β-Lactam Therapy Combined with Vancomycin or Daptomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia: a Systematic Review and Meta-analysis.

PubMed lists PMID 32839217 in Antimicrobial agents and chemotherapy as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2020-10-20 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Cetrorelix

Hepatic in vitro metabolism of peptides; Comparison of human liver S9, hepatocytes and Upcyte hepatocytes with cyclosporine A, leuprorelin, desmopressin and cetrorelix as model compounds.

PubMed lists PMID 33548873 in Journal of pharmaceutical and biomedical analysis as Journal Article, with publication-date metadata of 2021-01-27 (day precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Cetrorelix

Identification and structural elucidation of a new cetrorelix methylene dimer impurity in cetrorelix acetate by using LC-MS/MS.

PubMed lists PMID 33611089 in Journal of pharmaceutical and biomedical analysis as Journal Article, with publication-date metadata of 2021-02-03 (day precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Gallium Ga 68 dotatate

Doing Great With DOTATATE: Update on GA-68 DOTATATE Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging for Evaluation of Sinonasal Tumors.

PubMed lists PMID 34096898 in Topics in magnetic resonance imaging : TMRI as Journal Article, Review, with publication-date metadata of 2021-06-01 (day precision). PeptideScanner associated the retained record with the identity slug gallium-ga-68-dotatate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Dasiglucagon

ClinicalTrials.gov record NCT03378635

PeptideScanner retained ClinicalTrials.gov record NCT03378635 at 2026-11-16T01:42:39.027Z. Its registry update date was 2021-06-10, and PeptideScanner's reviewed identity mapping was dasiglucagon.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Semax

Composition of Colon Microbiota in Rats Treated with ACTH(4-7)-PGP Peptide (Semax) under Conditions of Restraint Stress.

PubMed lists PMID 32737723 in Bulletin of experimental biology and medicine as Journal Article, with publication-date metadata of 2020-08-01 (day precision). PeptideScanner associated the retained record with the identity slug semax. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Etelcalcetide

New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of working group on CKD-MBD of the Italian Society of Nephrology.

PubMed lists PMID 31853791 in Journal of nephrology as Journal Article, Practice Guideline, with publication-date metadata of 2019-12-18 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Gonadorelin

Spray congealed solid lipid microparticles as a sustained release delivery system for Gonadorelin [6-D-Phe]: Production, optimization and in vitro release behavior.

PubMed lists PMID 32599272 in European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V as Journal Article, with publication-date metadata of 2020-06-27 (day precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Regulatory · Octreotide

Federal Register notice 2021-11575

The Federal Register published notice 2021-11575, attributed to FDA and its parent HHS department, on 2021-06-02. Its official title is “Determination That SANDOSTATIN (Octreotide Acetate) Injection, Equal to 0.2 Milligrams Base/Milliliter and Equal to 1 Milligrams Base/Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Octreotide.

Source: Federal Register via GovInfo ↗

→

Literature metadata · Abaloparatide

Abaloparatide followed by alendronate in women ≥80 years with osteoporosis: post hoc analysis of ACTIVExtend.

PubMed lists PMID 32665529 in Menopause (New York, N.Y.) as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-10 (month precision). PeptideScanner associated the retained record with the identity slug abaloparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

May 2021

24 records on this page

Literature metadata · Dalbavancin

Dalbavancin Population Pharmacokinetic Modeling and Target Attainment Analysis.

PubMed lists PMID 31087630 in Clinical pharmacology in drug development as Clinical Trial, Phase II, Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-05-14 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Dalbavancin

Current trends in the real-life use of dalbavancin: report of a study panel.

PubMed lists PMID 32721599 in International journal of antimicrobial agents as Journal Article, Review, with publication-date metadata of 2020-07-25 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Teduglutide

Experience With Teduglutide in Pediatric Short Bowel Syndrome: First Real-life Data.

PubMed lists PMID 32804906 in Journal of pediatric gastroenterology and nutrition as Journal Article, with publication-date metadata of 2020-12 (month precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Daptomycin

Combination of Vancomycin or Daptomycin and Beta-lactam Antibiotics: A Meta-analysis.

PubMed lists PMID 32533859 in Pharmacotherapy as Journal Article, Meta-Analysis, Research Support, N.I.H., Extramural, with publication-date metadata of 2020-07-06 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Icatibant

Angioedema by MDMA mediated by bradykinin. Role of icatibant acetate.

PubMed lists PMID 32107042 in Medicina clinica as Letter, with publication-date metadata of 2020-02-24 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Terlipressin

Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence.

PubMed lists PMID 32676484 in Canadian journal of gastroenterology & hepatology as Journal Article, Systematic Review, with publication-date metadata of 2020-06-22 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

April 2021

2 records on this page

Clinical trials · Etelcalcetide

ClinicalTrials.gov record NCT03299244

PeptideScanner retained ClinicalTrials.gov record NCT03299244 at 2026-11-15T22:07:29.454Z. Its registry update date was 2021-04-30, and PeptideScanner's reviewed identity mapping was etelcalcetide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Difelikefalin

An evaluation of difelikefalin as a treatment option for moderate-to-severe pruritus in end stage renal disease.

PubMed lists PMID 33190563 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2020-12-14 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→